Clinical Trial Update: Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of inhaled insulin in individuals with Type 1 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Inhaled insulin (insulin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: TERMINATED